TOP STORIES

• BUSINESS Janssen Poised to Keep Up Double-Digit Growth, Focus on 5 Therapeutic Areas: Japan Pres. Goodwin
  April 3, 2013

• BUSINESS AZ Takes Over Rights to Byetta and Bydureon; Bydureon Expected to Be Launched in May
  April 2, 2013

• BUSINESS DSP Signs Agreement with Edison Pharmaceuticals of US for Mitochondrial Disease Treatments
  April 2, 2013

• ORGANIZATION Pharma Officials Puzzled at Fuzzy Communications Provision in JPMA Code of Practice
  April 1, 2013

• REGULATORY MOF Budget Examiner Hirotsugu Shinkawa Hopes to See New Generic Target Set at Highest Share Achievable at Fastest Pace
  March 29, 2013

• REGULATORY MHLW’s Generic Roadmap Compilation in Homestretch
  March 29, 2013

• BUSINESS Otsuka, Lundbeck to Jointly Develop, Market Alzheimer’s Disease Drug
  March 28, 2013

• BUSINESS ASKA Targets Sales of 50 Billion yen in FY2015, Up 20% vs. FY2012 Outlook: 3-Year Plan
  March 27, 2013

• BUSINESS New Settai Rules Halfway to Establishment; Some in Industry Want Further Rules as Well
  March 26, 2013

• BUSINESS Daiichi Sankyo Mulls Biz Platform after Olmesartan LOE: New 5 Year Plan
  March 25, 2013

• ORGANIZATION JPMA Officially Decides on One-Year Postponement of Individual Payment Disclosures under Transparency Guidelines
  March 22, 2013

• REGULATORY CSIMC Expert Member Yoshiaki Kamoya (Executive Officer, Shionogi) Says Price Cuts for Long-Listed Drugs and Perpetuation of Premium for New Drug Development Should Be Discussed Together
  March 22, 2013

• ORGANIZATION JPWA Vice President Ken Suzuki Expected to Lead JPWA After President Bessho’s Term Ends in May
  March 22, 2013

• BUSINESS Japan Pharmas Accelerating Drives to Set Up Medical Affairs Units
  March 21, 2013

• BUSINESS Alcon Japan, Kyowa Kirin Adjust Shipments of Anti-Allergy Drugs
  March 19, 2013

• ORGANIZATION Transparency Guidelines: JPMA Proposes One-Year Hold on Disclosure of Individual Payments
  March 18, 2013

• BUSINESS Eli Lilly Japan Files Tadalafil for BPH, 3rd NDA for Same API
  March 15, 2013

• REGULATORY Japan Pharmaceutical Association Vice President Hirotsugu Miura Says that 70% Rule for New Generics Will Be Debatable in Future
  March 15, 2013

• BUSINESS Sanofi Japan Aims to Enhance Leadership Status in Diabetes Sector with GLP-1, President Says
  March 14, 2013

• BUSINESS Biosimilar Makers Getting Premium-Linked Inquiries from Medical Institutions
  March 13, 2013

ページ

• « 先頭
• ‹ Prev
• …
• 221
• 222
• 223
• 224
• 225
• 226
• 227
• 228
• 229
• …
• Next ›
• 最終 »